PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15
Media Pack
News

Current Edition

Issue 9 Volume 1

Upcoming Events

SLAS
Bio IT
PEGS Boston
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost

Advertisement

A&M Stabtest April 26
Scientific Lab Show
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
QMB Innovation Centre
Polypure hompage
news

AstraZeneca and Daiichi set to broaden use of breast cancer drug, challenging Roche

Dive Brief: The Food and Drug Administration approved the antibody treatment Enhertu for earlier use in breast cancer patients, the latest milestone for a drug tha...
9 May 2022 news AstraZeneca | breast
Continue Reading →
news

Novartis breast cancer drug approved for ultra-rare condition

Dive Brief: The Food and Drug Administration has approved the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, grant...
11 April 2022 news breast | cancer
Continue Reading →
news

AstraZeneca, Daiichi press rivals with new results for breast cancer drug

Dive Brief: AstraZeneca and Daiichi Sankyo's antibody drug Enhertu could become standard treatment for a large group of breast cancer patients following Phase 3 st...
24 February 2022 news AstraZeneca | breast
Continue Reading →
The Bridge 28.01
Newcells 3 June 2024, 15:12
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Aseptic Tech
PharmExcel
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte